Public Profile
Vivek Subbiah, MD
- Chief, Early-Phase Drug Development
- Sarah Cannon Research Institute
| Program Name | Last Air Date | Hosts/Guests |
|---|---|---|
| Study Shows Importance of Comprehensive Genomic Profiling for NSCLC |
| Program Name | Last Air Date | Hosts/Guests |
|---|---|---|
| Study Shows Importance of Comprehensive Genomic Profiling for NSCLC |
